$WELL

Ventas (VTR) and Welltower (WELL) raised 2026 guidance and increased dividends. Ventas offers a higher current yield (2.4%) while Welltower has faster dividend growth (15% increase). Both have similar payout safety, but Welltower has lower debt. Ventas focuses on U.S. communities, while Welltower expands internationally.

Five REITs specializing in senior housing are highlighted due to a growing demand-supply gap driven by aging baby boomers. Welltower (WELL) and Ventas (VTR) report strong occupancy and revenue growth, while Omega Healthcare (OHI) offers a high yield but faces tenant credit risks. LTC Properties (LTC) and National Health Investors (NHI) are transitioning to more operating models. Key financial metrics and risks are detailed for each.

Brookdale Senior Living acquired 17 communities, reducing 2027 rent by $157M. It agreed to buy 30 more from Welltower, cutting 2027 rent by $290M. The deal, expected to close in Q4 2026, will increase Brookdale's owned units. A separate 39-community lease with Welltower was extended to 2036, with a $17.8M rent reduction. Brookdale's CEO expects these moves to boost Adjusted EBITDA and cash flow.

Welltower (WELL) raised its 2026 outlook, expecting same-store senior-housing NOI growth of around 19%. Guinness Global Real Assets Fund highlighted Welltower's favorable market conditions, with rising occupancy and limited new development. WELL's stock traded between $166.88 and $255.20 over the past year, closing at $230.29 on October 12, 2026, with a market cap of $165.64 billion.

Healthcare REITs like Ventas, Welltower, Healthpeak, and American Healthcare REIT are shifting focus to senior housing, moving away from medical office space. Welltower invested $15.5B in senior housing this year and sold $6B in medical office space. New entrants, including private equity and institutional capital, are now targeting medical office properties. Analysts expect $30B in healthcare REIT acquisitions by 2026.

Argus lowered its target price for National Health Investors (NHI) to $62, maintaining a HOLD rating. The company has medium industry, management, safety, and financial strength ratings, with low growth and value subratings.

WELL Health Technologies Corp. (WELL) shares fell 2.0% to C$4.39 today, attributed to the recent listing of its subsidiary WELLSTAR and increased debt. The company's debt rose to C$628.7 million due to acquisitions. Despite a positive broader market, WELL underperformed, highlighting stock-specific issues. Analysts maintain Buy ratings, and the next key event is Q3 2026 earnings in early November.

BMO Capital's Juan C. Sanabria maintained a Buy rating for Welltower (WELL) with a $265.00 price target. The stock has a Strong Buy consensus and $248.87 average target. Welltower reported Q2 revenue of $3.54B and net profit of $240.29M, up from $2.52B and $301.89M last year. Insider activity is positive, with recent purchases by directors.

ETFs sold a net $14.3M of Welltower (WELL) on Sept. 29, with DFAR, IYR, and LGLV among the largest sellers. This followed a $503.5M inflow on Monday. WELL is a healthcare REIT with a $165.5B market cap, reporting $12.75B in trailing-12-month revenue and a 25.38% YTD return.

Five senior housing REITs raised dividends in 2026, driven by strong demand. Welltower (WELL) and Ventas (VTR) lead in operating exposure, while Omega (OHI) and CareTrust (CTRE) focus on tenant credit and coverage. Dividend yields and coverage ratios vary, with Welltower offering the deepest buffer. Growth is fueled by acquisitions and equity raising, but risks include integration and operator stability.